Managers’ transactions
Faron Pharmaceuticals Ltd. (“Faron” or the “Company”) Managers’ transactions Company announcement, October 27, 2023 at 3:00 pm (EEST) Inside Information TURKU, Finland / BOSTON, Massachusetts – October 27 , 2023 - Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical-stage biopharmaceutical company pioneering macrophage reprogramming for effective anticancer immunotherapies, announces today that John Poulos, a Non-executive Director of the Company, on October 3, 2023 sold 5,000 ordinary shares in Faron at a price of €3.7209 per share, and on